Company TaiGen Biopharmaceuticals Holdings Limited

Equities

4157

KYG866171005

Biotechnology & Medical Research

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Sales per Business

Sales per region

Sector Bio Therapeutic Drugs

TAIGEN BIOPHARMACEUTICALS HOLDINGS LIMITED

End-of-day quote Taipei Exchange Other stock markets 06:00:00 2024-04-25 pm EDT			5-day change	1st Jan Change
15.4 ^TWD	-0.65%		-6.38%	+1.32%

Mar. 15	TaiGen Biopharmaceuticals Holdings Limited Reports Earnings Results for the Full Year Ended December 31, 2023	CI
2023	TaiGen Biopharmaceuticals Holdings Limited Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	CI

TAIGEN BIOPHARMACEUTICALS HOLDINGS LIMITED is a Taiwan-based company principally engaged in the research and production of pharmaceutical products. The Company's products mainly are new chemical entities (NCEs) in infectious diseases, cancer and diabetes-related complications. Its products include Nemonoxacin, Burlxafor and TG-2349. The Company receives its revenue mainly from the authorization of Nemonoxacin products.

TWD in Million	2022	Weight	2023	Weight	Delta
Development of Innovative New Drugs 96.8 %	36	100.0 %	119	96.8 %	+228.87%
Other 3.2 %	-	-	4	3.2 %	-

TWD in Million	2022	Weight	2023	Weight	Delta
China 75.2 %	0	0.0 %	93	75.2 %	-
Taiwan 24.8 %	21	58.0 %	31	24.8 %	+45.36%

Managers	Title	Age	Since
Philip Huang CEO	Chief Executive Officer	-	18-12-16
Richard Lue DFI	Director of Finance/CFO	-	16-03-31
Ming-Chu Hsu BRD	Director/Board Member	-	01-03-31
Hsuan Ju Wang IRC	Investor Relations Contact	-	-
MIng Tsung Kao AUD	Comptroller/Controller/Auditor	-	19-12-15
Chu Chung Lin PRN	Corporate Officer/Principal	-	-

Members of the board	Title	Age	Since
Shou-Chuan Ho BRD	Director/Board Member	-	13-04-28
Hong Jen Chang BRD	Director/Board Member	68	13-03-31
Sheng Fu Yu BRD	Director/Board Member	79	19-06-11
Weng Foung Huang BRD	Director/Board Member	-	11-06-23
Kuo-Hsi Wang BRD	Director/Board Member	-	09-03-02
Ming-Chu Hsu BRD	Director/Board Member	-	01-03-31
Philip Huang CEO	Chief Executive Officer	-	18-12-16
Yen Hua Huang BRD	Director/Board Member	-	07-12-30
Yeh Hung Chang BRD	Director/Board Member	-	19-06-11

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	717,844,175	358,926,175 ( 50.00 %)	0	50.00 %

Name	Equities	%	Valuation
First Securities Investment Trust Co. Ltd. 0.0246 %	176,514	0.0246 %	85 214 NT$

TaiGen Biopharmaceuticals Holdings Ltd.

7th Floor No. 138 Shinming Road

114 70, Taipei

http://www.taigenbiotech.com

address TaiGen Biopharmaceuticals Holdings Limited(4157)

Healthcare

Pharmaceuticals & Medical Research

Biotechnology & Medical Research

Biotechnology & Medical Research

Bio Therapeutic Drugs

	1st Jan change	Capi.
TAIGEN BIOPHARMACEUTICALS HOLDINGS LIMITED	+1.32%	339M
VERTEX PHARMACEUTICALS INCORPORATED	-2.31%	103B
REGENERON PHARMACEUTICALS, INC.	+0.56%	95.28B
ARGENX SE	+1.69%	22.15B
BIONTECH SE	-17.37%	21.02B
GENMAB A/S	-9.30%	18.15B
WUXI APPTEC CO., LTD.	-41.01%	16.73B
BEIGENE, LTD.	-14.85%	16.05B
NEUROCRINE BIOSCIENCES, INC.	+3.21%	13.68B
SAREPTA THERAPEUTICS, INC.	+33.54%	12.17B

Bio Therapeutic Drugs